Anavex Life Sciences Corp. beat EPS estimates 0% of the time across 2 reported quarters (0 beats, 2 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q12026 FY2026 | $-0.07 | — | — | Miss |
| Q12026 FY2026 | $-0.07 | $-0.13 | -85.7% | Miss |
| Q12026 FY2026 | $-0.07 | $-0.13 | -85.7% | Miss |
| Q12026 FY2026 | $-0.07 | — | — | Miss |
| Q12026 FY2026 | $-0.07 | — | — | Miss |
| 2026-05-19 | $-0.07 | — | — | Miss |
| 2026-05-18 | $-0.07 | — | — | Miss |
| 2026-05-12 | $-0.07 | — | — | Miss |
Back to AVXL overview · AVXL holders · AVXL KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.